Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.380
-0.140 (-9.21%)
At close: Mar 6, 2026, 4:00 PM EST
1.410
+0.030 (2.17%)
After-hours: Mar 6, 2026, 7:57 PM EST
PACB Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$2.10
Upside
+52.17%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold → Sell Downgrades $2 → $1.5 | Hold → Sell | Downgrades | $2 → $1.5 | +8.70% | Mar 6, 2026 |
| Barclays | Barclays | Hold Maintains $1.5 → $2 | Hold | Maintains | $1.5 → $2 | +44.93% | Dec 15, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $1.5 → $2 | Hold | Maintains | $1.5 → $2 | +44.93% | Nov 11, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $1.8 → $2 | Buy | Maintains | $1.8 → $2 | +44.93% | Nov 10, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $1.25 → $1.5 | Hold | Maintains | $1.25 → $1.5 | +8.70% | Aug 11, 2025 |
| Barclays | Barclays | Hold Maintains $2 → $1.5 | Hold | Maintains | $2 → $1.5 | +8.70% | Jun 25, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $2 → $1.25 | Hold | Maintains | $2 → $1.25 | -9.42% | May 15, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $1.8 | Buy | Reiterates | $1.8 | +30.43% | May 15, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +117.39% | Apr 10, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $6 → $2 | Buy | Maintains | $6 → $2 | +44.93% | Mar 25, 2025 |
| Piper Sandler | Piper Sandler | Hold Reiterates $2.5 → $2 | Hold | Reiterates | $2.5 → $2 | +44.93% | Feb 20, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $1.75 → $1.5 | Hold | Maintains | $1.75 → $1.5 | +8.70% | Feb 18, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +81.16% | Feb 18, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +81.16% | Feb 14, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $2.25 → $1.75 | Hold | Maintains | $2.25 → $1.75 | +26.81% | Jan 23, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades $2 | Strong Buy → Hold | Downgrades | $2 | +44.93% | Nov 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.